Workflow
BrightView(BV)
icon
Search documents
Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting
Prnewswire· 2025-06-11 12:14
-- BV Market Projected to Reach $1.0 Billion in the U.S. by 2033 -- -- BV Affects 21 Million U.S. Women; As many as 50% Experience Recurrent BV Within Six Months of Treatment -- SAN DIEGO, June 11, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM) today announced that a study of SOLOSEC® (secnidazole) 2 g oral granules for recurrent bacterial vaginosis (BV) presented at the 2025 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeti ...
BrightView(BV) - 2025 Q2 - Earnings Call Transcript
2025-05-08 13:32
BrightView (BV) Q2 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Chris Stoczko - VP - Finance & IRDale Asplund - President, CEO & DirectorBrett Urban - Executive VP & CFOBob Labick - PresidentLuke McFadden - Equity Research AssociateStephanie Moore - SVP - Equity ResearchZack Pacheco - Equity Research Associate Conference Call Participants Greg Palm - Senior Research AnalystGeorge Tong - Sr. Research Analyst - Equity ResearchAndrew Wittmann - Senior Research AnalystToni Kaplan - Executive ...
BrightView(BV) - 2025 Q2 - Earnings Call Transcript
2025-05-08 13:30
BrightView (BV) Q2 2025 Earnings Call May 08, 2025 08:30 AM ET Speaker0 Day, everyone, and welcome to today's BrightView Earnings Call. At this time, all participants are in a listen only mode. Later, you will have the opportunity to ask questions during the question and answer session. Please note this call may be recorded. I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Mr. Chris Stosco, Vice President of Finance and Investor Relations. Please ...
BrightView (BV) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2025-05-08 01:00
BrightView Holdings (BV) reported $662.6 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 1.5%. EPS of $0.14 for the same period compares to $0.11 a year ago. The reported revenue represents a surprise of +2.68% over the Zacks Consensus Estimate of $645.33 million. With the consensus EPS estimate being $0.12, the EPS surprise was +16.67%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to d ...
BrightView Holdings (BV) Surpasses Q2 Earnings and Revenue Estimates
ZACKS· 2025-05-08 00:25
BrightView Holdings (BV) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 16.67%. A quarter ago, it was expected that this investment company would post earnings of $0.04 per share when it actually produced earnings of $0.04, delivering no surprise.Over the last four quarters, the comp ...
BrightView(BV) - 2025 Q2 - Quarterly Results
2025-05-07 20:14
Exhibit 99.1 BRIGHTVIEW POSTS SECOND QUARTER FISCAL 2025 EARNINGS WITH RECORD ADJUSTED EBITDA AND RAISES FULL YEAR GUIDANCE BLUE BELL, PA, May 7, 2025 -- BrightView Holdings, Inc. (NYSE: BV) (the "Company" or "BrightView"), the leading commercial landscaping services company in the United States, today reported unaudited results for the second quarter ended March 31, 2025. SECOND QUARTER FISCAL 2025 SUMMARY COMPANY UPDATES FISCAL YEAR 2025 GUIDANCE 1 | | Prior Guidance | Updated Guidance | | --- | --- | --- ...
BrightView(BV) - 2025 Q2 - Quarterly Report
2025-05-07 20:13
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38579 BrightView Holdings, Inc. (Exact name of Registrant as specified in its Charter) Delaware 46-4190788 ( State or other jur ...
BrightView(BV) - 2025 Q1 - Earnings Call Presentation
2025-02-06 21:32
1Q FY2025 Earnings Presentation | 2 First Quarter Fiscal 2025 | Earnings Call February 6, 2025 NYSE: BV Introductory Information Introductory Information (continued) 1Q FY2025 Earnings Presentation | 3 Executive Summary Dale Asplund | President & Chief Executive Officer 1Q FY2025 Earnings Presentation | 4 Key Highlights Continue to embrace a unified One BrightView culture One BrightView Transformation Progressing – Reiterating FY25 Guidance Delivered double-digit EBITDA growth and expanded margins by 120 bp ...
BrightView(BV) - 2025 Q1 - Earnings Call Transcript
2025-02-06 20:22
BrightView Holdings, Inc. (NYSE:BV) Q1 2025 Earnings Conference Call February 6, 2025 8:30 AM ET Company Participants Chris Stoczko - Vice President of Finance and Investor Relations Dale Asplund - President and Chief Executive Officer Brett Urban - Chief Financial Officer Conference Call Participants Tim Mulrooney - William Blair Bob Labick - CJS Securities Greg Palm - Craig-Hallum Capital Group Jeffrey Stevenson - Loop Capital George Tong - Goldman Sachs Andy Wittmann - Baird Harold Antor - Jefferies Alex ...
BrightView(BV) - 2025 Q1 - Earnings Call Transcript
2025-02-06 14:30
BrightView (BV) Q1 2025 Earnings Call February 06, 2025 08:30 AM ET Company Participants Chris Stoczko - Vice President of FinanceDale Asplund - President & CEOBrett Urban - Executive VP & CFOBob Labick - PresidentJeffrey Stevenson - Vice PresidentHarold Antor - Senior Equity Research AssociateAlexander Hess - Vice President - Equity ResearchCarl Reichardt - Managing Director - Equity Research Conference Call Participants Tim Mulrooney - Equity Research AnalystGreg Palm - Senior Research AnalystGeorge Tong ...